These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23190513)

  • 1. Type II diabetes mellitus is a risk factor for heart failure in pre-dialysis patients.
    Kuwahara M; Ishigami J; Shikuma S; Akita W; Mori Y; Asai T; Tsukamoto Y; Adachi S; Noda Y; Rai T; Uchida S; Sasaki S
    Ther Apher Dial; 2012 Dec; 16(6):541-7. PubMed ID: 23190513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, prognosis, and therapeutic implications of unrecognized left ventricular systolic dysfunction in patients with anemia and chronic kidney disease.
    Bhatti S; Hakeem A; Dillie KS; Cook JR; Chang SM
    Congest Heart Fail; 2010; 16(6):271-7. PubMed ID: 21091612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.
    Das SR; Drazner MH; Yancy CW; Stevenson LW; Gersh BJ; Dries DL
    Am Heart J; 2004 Nov; 148(5):883-8. PubMed ID: 15523322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
    McAlister FA; Ezekowitz J; Tarantini L; Squire I; Komajda M; Bayes-Genis A; Gotsman I; Whalley G; Earle N; Poppe KK; Doughty RN;
    Circ Heart Fail; 2012 May; 5(3):309-14. PubMed ID: 22441773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.
    Kottgen A; Russell SD; Loehr LR; Crainiceanu CM; Rosamond WD; Chang PP; Chambless LE; Coresh J
    J Am Soc Nephrol; 2007 Apr; 18(4):1307-15. PubMed ID: 17344421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the Heart of the Heart Study.
    McGrady M; Krum H; Carrington MJ; Stewart S; Zeitz C; Lee GA; Marwick TH; Haluska BA; Brown A
    Heart; 2012 Nov; 98(21):1562-7. PubMed ID: 22888160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction.
    Edwards NC; Ferro CJ; Townend JN; Steeds RP
    Heart; 2008 Aug; 94(8):1038-43. PubMed ID: 18308865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitral valve repair for medically refractory functional mitral regurgitation in patients with end-stage renal disease and advanced heart failure.
    Kainuma S; Taniguchi K; Daimon T; Sakaguchi T; Funatsu T; Miyagawa S; Kondoh H; Takeda K; Shudo Y; Masai T; Ohishi M; Sawa Y
    Circulation; 2012 Sep; 126(11 Suppl 1):S205-13. PubMed ID: 22965985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
    Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
    Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure in patients with chronic kidney disease.
    Lisowska A; Musiał WJ
    Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment.
    Pecoits-Filho R; Bucharles S; Barberato SH
    Semin Dial; 2012; 25(1):35-41. PubMed ID: 22273530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure.
    Afshinnia F; Spitalewitz S; Chou SY; Gunsburg DZ; Chadow HL
    Am J Kidney Dis; 2007 Feb; 49(2):227-36. PubMed ID: 17261425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas.
    Zamora E; Lupón J; Vila J; Urrutia A; de Antonio M; Sanz H; Grau M; Ara J; Bayés-Genís A
    J Am Coll Cardiol; 2012 May; 59(19):1709-15. PubMed ID: 22554602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
    Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.